Stock listing
gettex:8CC Cocrystal Pharma, Inc. Aktie
German listing (gettex) of Cocrystal Pharma, Inc. · home listing NASDAQ:COCP
Follow Cocrystal Pharma, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:COCP
$0.995 USD +0.015 (+1.5%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:COCP
- Day range
- $0.950 – $1.008 USDOct 30, 2026
- Volume
- 62,764 sharesOct 30, 2026
- Market cap
- $19.17M USDAt the close on Oct 30, 2026 · price × 19.26M shares outstanding
- 52-week range
- $0.760 – $2.030 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $61,979 USDMedian day 42,050 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:COCP · Home | $0.995 USD | +0.015 (+1.5%) | 62,764 | $0.950 | $1.008 | $0.950 | $0.980 | Close on Oct 30, 2026 |
| Frankfurt:8CC | €0.84 EUR | +0.02 (+2.4%) | — | €0.84 | €0.84 | €0.84 | €0.82 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:COCP · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.995 | +0.015 | +1.5% | $0.950 | $1.008 | $0.950 | 62,764 | |
| $0.980 | -0.010 | -1.0% | $0.970 | $0.980 | $0.970 | 14,735 | |
| $0.990 | +0.009 | +0.9% | $0.981 | $1.000 | $0.970 | 32,735 | |
| $0.981 | +0.009 | +0.9% | $0.940 | $1.000 | $0.940 | 15,380 | |
| $0.972 | +0.022 | +2.3% | $0.970 | $1.010 | $0.962 | 21,940 | |
| $0.950 | +0.040 | +4.4% | $0.920 | $1.070 | $0.920 | 43,500 | |
| $0.910 | -0.030 | -3.2% | $0.940 | $1.000 | $0.910 | 17,100 | |
| $0.940 | 0.000 | 0.0% | $0.970 | $0.970 | $0.930 | 7,500 | |
| $0.940 | -0.010 | -1.1% | $0.910 | $0.980 | $0.910 | 15,300 | |
| $0.950 | -0.070 | -6.9% | $1.010 | $1.020 | $0.910 | 152,300 | |
| $1.020 | -0.010 | -1.0% | $1.040 | $1.060 | $1.010 | 22,800 | |
| $1.030 | -0.010 | -1.0% | $1.020 | $1.060 | $1.010 | 45,500 | |
| $1.040 | -0.040 | -3.7% | $1.050 | $1.080 | $1.040 | 46,000 | |
| $1.080 | +0.020 | +1.9% | $1.050 | $1.110 | $1.020 | 86,700 | |
| $1.060 | -0.010 | -0.9% | $1.070 | $1.080 | $1.050 | 9,000 | |
| $1.070 | 0.000 | 0.0% | $1.060 | $1.080 | $1.060 | 4,000 | |
| $1.070 | +0.010 | +0.9% | $1.060 | $1.100 | $1.060 | 29,000 | |
| $1.060 | -0.050 | -4.5% | $1.110 | $1.110 | $1.060 | 30,200 | |
| $1.110 | 0.000 | 0.0% | $1.110 | $1.130 | $1.100 | 28,500 | |
| $1.110 | -0.040 | -3.5% | $1.180 | $1.180 | $1.110 | 41,200 | |
| $1.150 | +0.010 | +0.9% | $1.170 | $1.170 | $1.140 | 13,700 | |
| $1.140 | -0.010 | -0.9% | $1.180 | $1.180 | $1.120 | 68,000 | |
| $1.150 | +0.030 | +2.7% | $1.140 | $1.190 | $1.120 | 12,700 | |
| $1.120 | -0.090 | -7.4% | $1.240 | $1.240 | $1.100 | 121,000 | |
| $1.210 | +0.040 | +3.4% | $1.190 | $1.220 | $1.150 | 32,100 | |
| $1.170 | +0.020 | +1.7% | $1.180 | $1.180 | $1.140 | 13,400 | |
| $1.150 | -0.040 | -3.4% | $1.210 | $1.210 | $1.130 | 47,900 | |
| $1.190 | 0.000 | 0.0% | $1.170 | $1.280 | $1.160 | 26,100 | |
| $1.190 | 0.000 | 0.0% | $1.210 | $1.280 | $1.190 | 69,000 | |
| $1.190 | -0.020 | -1.7% | $1.200 | $1.250 | $1.190 | 41,100 | |
| $1.210 | +0.070 | +6.1% | $1.140 | $1.250 | $1.140 | 176,500 | |
| $1.140 | 0.000 | 0.0% | $1.140 | $1.150 | $1.120 | 13,800 | |
| $1.140 | 0.000 | 0.0% | $1.130 | $1.170 | $1.110 | 46,800 | |
| $1.140 | -0.030 | -2.6% | $1.210 | $1.230 | $1.120 | 34,000 | |
| $1.170 | -0.070 | -5.6% | $1.270 | $1.270 | $1.170 | 23,100 | |
| $1.240 | +0.010 | +0.8% | $1.260 | $1.290 | $1.220 | 58,500 | |
| $1.230 | -0.010 | -0.8% | $1.260 | $1.280 | $1.220 | 53,600 | |
| $1.240 | +0.060 | +5.1% | $1.180 | $1.290 | $1.180 | 111,300 | |
| $1.180 | +0.050 | +4.4% | $1.150 | $1.200 | $1.120 | 61,400 | |
| $1.130 | 0.000 | 0.0% | $1.120 | $1.140 | $1.100 | 42,900 | |
| $1.130 | -0.030 | -2.6% | $1.160 | $1.160 | $1.120 | 29,200 | |
| $1.160 | +0.040 | +3.6% | $1.150 | $1.170 | $1.110 | 55,200 | |
| $1.120 | -0.040 | -3.4% | $1.170 | $1.170 | $1.100 | 34,800 | |
| $1.160 | +0.060 | +5.5% | $1.100 | $1.160 | $1.100 | 48,300 | |
| $1.100 | -0.040 | -3.5% | $1.180 | $1.180 | $1.100 | 28,700 | |
| $1.140 | +0.020 | +1.8% | $1.100 | $1.170 | $1.100 | 44,900 | |
| $1.120 | -0.010 | -0.9% | $1.130 | $1.170 | $1.120 | 18,800 | |
| $1.130 | +0.020 | +1.8% | $1.110 | $1.180 | $1.100 | 71,800 | |
| $1.110 | -0.040 | -3.5% | $1.190 | $1.190 | $1.100 | 46,000 | |
| $1.150 | -0.020 | -1.7% | $1.190 | $1.210 | $1.100 | 84,200 | |
| $1.170 | +0.020 | +1.7% | $1.160 | $1.230 | $1.130 | 175,900 | |
| $1.150 | +0.070 | +6.5% | $1.100 | $1.150 | $1.070 | 65,400 | |
| $1.080 | -0.010 | -0.9% | $1.080 | $1.110 | $1.070 | 64,400 | |
| $1.090 | -0.030 | -2.7% | $1.140 | $1.150 | $1.090 | 30,000 | |
| $1.120 | +0.020 | +1.8% | $1.070 | $1.130 | $1.070 | 38,300 | |
| $1.100 | -0.020 | -1.8% | $1.110 | $1.150 | $1.100 | 36,000 | |
| $1.120 | +0.040 | +3.7% | $1.120 | $1.120 | $1.080 | 51,400 | |
| $1.080 | 0.000 | 0.0% | $1.080 | $1.140 | $1.060 | 75,500 | |
| $1.080 | +0.020 | +1.9% | $1.120 | $1.170 | $1.060 | 232,100 | |
| $1.060 | +0.030 | +2.9% | $1.060 | $1.090 | $0.970 | 54,200 | |
| $1.030 | +0.010 | +1.0% | $1.030 | $1.050 | $1.030 | 30,900 | |
| $1.020 | +0.040 | +4.1% | $1.000 | $1.020 | $0.930 | 69,000 | |
| $0.980 | +0.040 | +4.3% | $0.970 | $1.040 | $0.960 | 116,100 | |
| $0.940 | +0.120 | +14.6% | $0.870 | $1.000 | $0.850 | 417,400 | |
| $0.820 | -0.050 | -5.7% | $0.880 | $0.890 | $0.820 | 34,900 | |
| $0.870 | 0.000 | 0.0% | $0.870 | $0.870 | $0.850 | 23,400 |
- Ticker
- gettex:8CC
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- gettex
- Currency
- EUR
What changed lately
Latest news release · Sep 9, 2026
Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment
Latest deck · Apr 30, 2026
2026 International Society For Antiviral Research (ICAR 2026)
Conference · 17 slides
Latest news
Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment
Sep 9, 2026
Closed $1.24 (+5.1%) on Sep 9, 2026
Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors
Aug 17, 2026
Closed $1.09 (-2.7%) on Aug 17, 2026
Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health
Aug 3, 2026
Closed $0.94 (+14.6%) on Aug 3, 2026
Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader with Extensive Antiviral Development Experience, as Chief Executive Officer
Jun 3, 2026
Closed $1.06 (+1.0%) on Jun 3, 2026
Cocrystal Pharma Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus and Influenza
May 26, 2026
Closed $1.13 (-1.7%) on May 26, 2026
Cocrystal Pharma Provides Business Update and Reports First Quarter 2026 Financial Results
May 15, 2026
Closed $1.20 (-4.8%) on May 15, 2026
COCP: Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Prevention
Apr 7, 2026
Closed $1.47 (-2.0%) on Apr 7, 2026
Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive
Apr 2, 2026
Closed $1.51 (+48.0%) on Apr 2, 2026
Cocrystal Pharma Reports 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
Mar 31, 2026
Closed $1.01 (+1.0%) on Mar 31, 2026
First Subjects Dosed in Cocrystal Pharma’s Phase 1b Study Evaluating CDI-988 for Norovirus Prevention and Treatment
Mar 9, 2026
Closed $1.03 (+2.0%) on Mar 9, 2026
Financings
Private placement of common stock
Aug 3, 2026
Closed: US$5M raised · US$0.9134 a share
Buyers: OPKO (5,474,053 shares of common stock for $5.0 million)
Decks
2026 International Society For Antiviral Research (ICAR 2026)
Conference · 17 slides · Apr 30, 2026
Investor Presentation (April 2026)
Investor deck · 29 slides · April 2026
2025 International Calicivirus Conference
Conference · 25 slides · Sep 11, 2025
2025 Military Health System Research Symposium
Conference · 21 slides · Aug 5, 2025
Cocrystal Pharma, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 15 in the last 12 months · 152 in all · newest Sep 9, 2026 · oldest 2019
- Decks
- 29 decks · latest Apr 30, 2026
Where Cocrystal Pharma, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:COCP · Home listing | NASDAQ | United States | USD |
| Tradegate:8CC | Tradegate | Germany | EUR |
| Lang & Schwarz:A3DWYX | Lang & Schwarz | Germany | EUR |
| LS Exchange:A3DWYX | LS Exchange | Germany | EUR |
| gettex:8CC · This page | gettex | Germany | EUR |
| BOATS:COCP | BOATS | United States | USD |
| Dusseldorf:8CC | Dusseldorf | Germany | EUR |
| Frankfurt:8CC | Frankfurt | Germany | EUR |
| Munich:8CC | Munich | Germany | EUR |
| Stuttgart:8CC | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Cocrystal Pharma, Inc.